Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 394Precursor Cell Lymphoblastic Leukemia-Lymphoma 226Hematologic Neoplasms 206Leukemia, Lymphocytic, Chronic, B-Cell 175Myelodysplastic Syndromes 144Leukemia 125Lymphoma 90Lymphoma, Non-Hodgkin 76Multiple Myeloma 67Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67Recurrence 55Neoplasms 53Leukemia, Myelomonocytic, Chronic 50Burkitt Lymphoma 44Lymphoma, Large B-Cell, Diffuse 41Leukemia, Biphenotypic, Acute 41Myeloproliferative Disorders 39Lymphoma, Mantle-Cell 39Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 37Hodgkin Disease 36Lymphoma, B-Cell 32Lymphoma, Follicular 31Leukemia, B-Cell 27Lymphoma, B-Cell, Marginal Zone 24Anemia, Refractory, with Excess of Blasts 24Waldenstrom Macroglobulinemia 23Primary Myelofibrosis 21Myelodysplastic-Myeloproliferative Diseases 20Hematologic Diseases 19Lymphoma, T-Cell 16

Interventions

Clinical Trials, Phase I as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemoglobinopathies × Other hematologic neoplasm × 90 days × Clear all
NCT06839456 2026-04-15

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Children's Hospital of Philadelphia

Phase 1/2 Recruiting
100 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Non-Hodgkin, Metabolism, Inborn Errors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡